Preclinical CRO Market Outlook

A preclinical contract research organization (CRO) refers to a support center, which provides expertise in research and development (R&D). It ensures that a therapeutic gadget or medication is successfully developed and sheltered before being launched in the market. In addition to this, preclinical CRO offers services that assist in clearing a pharmaceutical item through animal testing and advancing it to the clinical phase. It also provides critical studies to the restorative workforce, various industries, researchers, legislative contacts, etc., for assessing drug efficacy and safety in animal models and completing investigational new drug (IND) filing studies.

The global preclinical CRO market size reached US$ 5.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 8.2 Billion by 2027, exhibiting a growth rate (CAGR) of 8% during 2022-2027.

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

Preclinical CRO Market Trends:

The escalating demand for effective drugs and healthcare devices, on account of rising prevalence of chronic diseases, including cardiovascular diseases (CVDs), cancer, diabetes, etc., is primarily driving the preclinical CRO market. Additionally, preclinical CRO offers several end-to-end services, such as toxicology testing, immunization trials, bio-identity study, etc., which are also catalyzing the market growth. Apart from this, continuous upgradations in drug approval processes by the Food and Drug Administration (FDA), such as evaluation of the report, monitoring investigations, design of a protocol, etc., are further augmenting the global market. Moreover, numerous technological advancements, including the development of fast approval processes to analyze patterns and identify molecular compounds for drug discovery activities, are anticipated to fuel the preclinical CRO market over the forecasted period.

Request For a Free PDF Sample Report: https://www.imarcgroup.com/preclinical-cro-market/requestsample

Note: In this report you will get detailed analysis of the market, growth analysis graphs, historical period analysis, forecast period analysis, major market segmentation, top leading key players of the market, table of content, list of figures, and list of tables.

Competitive Landscape with Key Players:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

  • Charles River Laboratories Inc.
  • Covance Inc. (Laboratory Corporation of America Holdings)
  • Eurofins Scientific
  • ICON Plc
  • MD Biosciences Inc. (MLM Medical Labs)
  • Medpace, Parexel International Corporation
  • PPD Inc.
  • Wuxi AppTec.

Key Market Segmentation:

The report has categorized the market based on service, end use and Region.

Breakup by Service:

  • Bioanalysis and DMPK Studies
  • Toxicology Testing
  • Others

Breakup by End Use:

  • Biopharmaceutical Companies
  • Government and Academic Institutes
  • Medical Device Companies

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)

Key Highlights of The Report:                                                    

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

134 N 4th St.

Brooklyn, NY 11249, USA

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800